NYSE:AEON | Profit Breakdown | AEON Biopharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$5.92M-$1.16M-$1.16M
2026-03-31-$5.93M-$11.79M-$11.79M
2025-12-31-$5.51M-$37.14M-$37.14M
2025-09-30-$2.49M-$4.54M-$4.54M
2025-06-30-$4.34M-$6.64M-$6.64M
2025-03-31-$462,000.00$9.1M$9.1M
2024-12-31-$2.32M$2.08M$2.08M
2024-09-30-$4.02M-$6.17M-$6.17M
2024-06-30$153.47M$164.11M$164.11M
2024-03-31-$74.15M-$118.02M-$118.02M
2023-09-30-$283.71M-$297.71M-$297.71M
2023-06-30-$13.97M-$15.38M-$15.38M
2023-03-31-$13.05M-$17.64M-$17.64M
2022-12-31-$15.03M-$34.56M-$34.56M
2022-09-30-$9.91M-$10.44M-$10.44M
2022-06-30-$427,204.00$1.88M$1.87M
2022-03-31-$389,073.00$2.77M$2.77M
2021-12-31-$885,744.00$247,874.00$247,874.00
2021-09-30-$450,892.00$5.66M$5.66M
2021-06-30-$398,443.00-$4.03M-$4.03M
2021-03-31-$200,863.00$6.32M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$12.8M-$39.22M-$39.22M
2024-12-31$72.99M$42.01M$42.01M
2022-12-31-$48.43M-$52.56M-$52.56M
2021-12-31-$1.94M$8.2M$8.2M